Working group: More guidance needed on MRD in myeloma trials
Regulatory NewsMary Ellen Schneider
BiologicsClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsMary Ellen SchneiderBiologicsClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy